Pitfalls in diagnosis with the use of circulating tumor‐derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M

The circulating tumor DNA (ctDNA) assay has recently been approved for the selection of EGFR‐tyrosine kinase inhibitors as first‐line treatment in lung cancer. However, it remains to be determined whether this assay can detect all complex EGFR mutations within a single tumor. We report a case of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawara, Daiki, Soda, Hiroshi, Suyama, Takayuki, Yoshida, Masataka, Harada, Tatsuhiko, Fukuda, Yuichi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754312/
https://www.ncbi.nlm.nih.gov/pubmed/29063709
http://dx.doi.org/10.1111/1759-7714.12538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754312/
https://www.ncbi.nlm.nih.gov/pubmed/29063709
http://dx.doi.org/10.1111/1759-7714.12538

Ejemplares similares